Why multipotent progenitor cells matter for patients receiving bone marrow transplants

Rong Lu Lab (Photo by Chris Shinn)
Rong Lu Lab (Photo by Chris Shinn)

When patients receive bone marrow transplants, they are infused with complex admixtures of many different cell types with the power to regenerate their blood and immune systems. In a new study in Experimental & Molecular Medicine, scientists from the USC Stem Cell laboratory of Rong Lu share new discoveries about the influence of multipotent progenitor cells (MPPs) that are co-transplanted along with stem cells during bone marrow transplants.

“This is the first study to investigate the influence of MPPs, which we found stimulated stem cells to produce more T cells,” said Lu, the study’s corresponding author and an associate professor of stem cell biology, biomedical engineering, medicine, and gerontology at USC. “Improving T cell production in bone marrow transplantation can help prevent infections, a major complication that can be fatal for patients undergoing this treatment.”

To read more, visit https://stemcell.keck.usc.edu/why-multipotent-progenitor-cells-matter/.